OpenURL Connection Search

Select item for more details and to access through your institution.

Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
Published in:
1993
By:
- Case, Delvyn C.;
- Bukowski, Ronald M.;
- Carey, Robert W.;
- Fishkin, Ellioth H.;
- Henry, David H.;
- Jacobson, Robert J.;
- Jones, Steven E.;
- Keller, Allan M.;
- Kugler, John W.;
- Nichols, Craig R.;
- Salmon, Sydney E.;
- Silver, Richard T.;
- Storniolo, Anna Maria;
- Wampler, Galen L.;
- Dooley, Cathleen M.;
- Larholt, Kay M.;
- Nelson, Richard A.;
- Abels, Robert I.;
- Case, D C Jr;
- Bukowski, R M
Publication type:
journal article
Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia.
Published in:
2012
By:
- Pashos CL;
- Larholt K;
- Fraser KA;
- McKenzie RS;
- Senbetta M;
- Piech CT;
- Pashos, Chris L;
- Larholt, Kay;
- Fraser, Kimberly A;
- McKenzie, R Scott;
- Senbetta, Mekré;
- Piech, Catherine Tak
Publication type:
journal article
Dosing and Outcomes Study ofÂ Erythropoiesis-Stimulating Therapies (DOSE): A Registry for Characterizing Anaemia Management andÂ Outcomes in Oncology Patients.
Published in:
Clinical Drug Investigation, 2008, v. 28, n. 3, p. 159, doi. 10.2165/00044011-200828030-00003
By:
- Larholt, Kay;
- Pashos, Chris L.;
- Qin Wang;
- Bookhart, Brahim;
- McKenzie, R. Scott;
- Piech, Catherine Tak
Publication type:
Article
A Useful and Sustainable Role for N‐of‐1 Trials in the Healthcare Ecosystem.
Published in:
Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 224, doi. 10.1002/cpt.2425
By:
- Selker, Harry P.;
- Cohen, Theodora;
- D'Agostino, Ralph B.;
- Dere, Willard H.;
- Ghaemi, S. Nassir;
- Honig, Peter K.;
- Kaitin, Kenneth I.;
- Kaplan, Heather C.;
- Kravitz, Richard L.;
- Larholt, Kay;
- McElwee, Newell E.;
- Oye, Kenneth A.;
- Palm, Marisha E.;
- Perfetto, Eleanor;
- Ramanathan, Chandra;
- Schmid, Christopher H.;
- Seyfert‐Margolis, Vicki;
- Trusheim, Mark;
- Eichler, Hans‐Georg
Publication type:
Article
Precision Reimbursement for Precision Medicine: Using Real‐World Evidence to Evolve From Trial‐and‐Project to Track‐and‐Pay to Learn‐and‐Predict.
Published in:
Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 1, p. 52, doi. 10.1002/cpt.2471
By:
- Eichler, Hans‐Georg;
- Trusheim, Mark;
- Schwarzer‐Daum, Brigitte;
- Larholt, Kay;
- Zeitlinger, Markus;
- Brunninger, Martin;
- Sherman, Michael;
- Strutton, David;
- Hirsch, Gigi
Publication type:
Article

Found: 5

Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia.

Dosing and Outcomes Study ofÂ Erythropoiesis-Stimulating Therapies (DOSE): A Registry for Characterizing Anaemia Management andÂ Outcomes in Oncology Patients.

A Useful and Sustainable Role for N‐of‐1 Trials in the Healthcare Ecosystem.

Precision Reimbursement for Precision Medicine: Using Real‐World Evidence to Evolve From Trial‐and‐Project to Track‐and‐Pay to Learn‐and‐Predict.